Codes / ICD10CM / T40.723S

T40.723S Poisoning by synthetic cannabinoids, assault, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common name: Assault-related synthetic cannabinoid poisoning sequela
  • Medical terms: Poisoning by synthetic cannabinoids due to assault, sequela

Summary

This ICD code applies to the residual effects or complications following poisoning by synthetic cannabinoids resulting from assault. It covers conditions that persist after the acute phase of the poisoning, where exposure was non-consensual and intended to cause harm. The sequela may involve ongoing physical or psychological effects requiring continued medical attention.

Causes

Sequela in this context result from prior poisoning by synthetic cannabinoids during an assault. The initial exposure involved deliberate, non-consensual administration by an assailant, leading to toxic effects. The residual effects arise from the body’s response to the initial poisoning, which may include tissue damage, organ dysfunction, or persistent neurological or psychological symptoms.

Risk Factors

  • History of assault-related synthetic cannabinoid poisoning
  • Severity of the initial poisoning episode
  • Delayed or inadequate initial treatment
  • Pre-existing health conditions that may complicate recovery
  • Psychological trauma associated with the assault

Symptoms

  • Persistent anxiety, paranoia, or mood disturbances
  • Chronic headaches or cognitive impairment
  • Respiratory issues (e.g., shortness of breath, reduced lung function)
  • Gastrointestinal problems (e.g., recurrent nausea, abdominal pain)
  • Cardiovascular abnormalities (e.g., irregular heart rate, hypertension)
  • Sleep disturbances or fatigue
  • Psychological effects such as post-traumatic stress disorder (PTSD)

Diagnosis

Diagnosis involves a clinical evaluation focusing on the history of the prior assault-related poisoning and current symptoms. Medical records of the initial event are reviewed to confirm the cause. Physical examinations, laboratory tests, and imaging may be used to assess residual organ damage or ongoing physiological effects. Psychological assessments may be necessary to evaluate mental health sequelae.

Treatment Options

Treatment targets the specific residual effects and may include:

  • Medications to manage chronic symptoms (e.g., antidepressants, anxiolytics, or cardiovascular drugs)
  • Rehabilitation therapies (e.g., physical, occupational, or speech therapy) for functional impairments
  • Psychological counseling or therapy for trauma-related symptoms
  • Monitoring and management of chronic conditions resulting from the initial poisoning
  • Supportive care to address ongoing discomfort or disability

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the nature of the residual effects. Some individuals may experience full recovery, while others may have lasting impairments. Regular follow-up is essential to monitor symptoms, adjust treatments, and address any new complications. Long-term care may be required for persistent physical or psychological effects.

Complications

  • Chronic organ damage (e.g., liver, kidney, or cardiovascular)
  • Persistent neurological deficits (e.g., memory loss, coordination issues)
  • Development of substance use disorders or psychological conditions (e.g., PTSD, depression)
  • Reduced quality of life due to ongoing symptoms or disability
  • Increased risk of future health issues related to the initial poisoning

Lifestyle & Prevention

  • Avoid situations where assault or non-consensual exposure to substances is possible
  • Seek prompt medical care after any suspected poisoning to minimize long-term effects
  • Follow recommended treatment plans and attend all follow-up appointments
  • Engage in stress-reduction techniques or therapy to address psychological impacts
  • Maintain a healthy lifestyle (e.g., balanced diet, regular exercise) to support recovery

When to Seek Professional Help

  • Worsening or new symptoms (e.g., severe pain, difficulty breathing, or changes in mental status)
  • Signs of psychological distress (e.g., persistent anxiety, flashbacks, or suicidal thoughts)
  • Unexplained physical changes (e.g., swelling, persistent fatigue, or unusual bleeding)
  • Concerns about the effectiveness of current treatments or management of symptoms

Tips for Medical Coders

This code is used for sequela (residual effects) of poisoning by synthetic cannabinoids due to assault. Document the relationship between the prior assault-related poisoning and the current condition, including the time elapsed since the initial event. Ensure the sequela is directly attributable to the poisoning and not another cause. Code T40.723S should be used when the sequela is the focus of treatment or evaluation.

Book a walkthrough

T40.723S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.